• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

DIABETES MELLITUS PSEUDOMONAS AERUGINOSA STAPHYLOCOCCUS AUREUS CTLA4 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DEATH IMMUNE RESPONSE BREAST CANCER PORPHYROMONAS GINGIVALIS CANDIDA ALBICANS INSULIN LISTERIA MONOCYTOGENES DOXORUBICIN IL17A SOD1 ANGIOGENESIS CD4 ESCHERICHIA COLI APOPTOTIC PROCESS TH17 CELLS CELL DIFFERENTIATION FOXP3 ERBB-2 AGING IL6 NEURODEGENERATIVE DISORDERS CELL DIVISION IFNG CELL PROLIFERATION INFLAMMATION RECEPTOR PARKINSON DISEASE AUTOPHAGY CASP3 HELICOBACTER PYLORI TP53 REMICADE CLOSTRIDIUM DIFFICILE METFORMIN RHEUMATOID ARTHRITIS TNF CANCER ALZHEIMER'S DISEASE IL23A STREPTOCOCCUS PNEUMONIAE

© 2019 Biovista Vizit All Rights Reserved.